M. Furutani et al., DECREASED EXPRESSION AND RARE SOMATIC MUTATION OF THE CIP1 WAF1 GENE IN HUMAN HEPATOCELLULAR-CARCINOMA/, Cancer letters, 111(1-2), 1997, pp. 191-197
CIP1/WAF1, a critical downstream effector of tumor suppressor p53, enc
odes a cyclin-dependent kinase inhibitor. By Northern blot analysis, t
he CIP1/WAF1 mRNA level in the tumor was significantly lower than that
in the corresponding normal liver from 19 Japanese patients with hepa
tocellular carcinoma P <0.05). In the tumor from only one; out of 19 p
atients (5%), somatic mutations of the CIP1/WAF1 as well as that of p5
3 gene were identified by RT-PCR/SSCP analysis. These results suggest
that the decreased CIP1/WAF1 expression is involved in the carcinogene
sis or the progression of hepatocellular carcinoma. (C) 1997 Elsevier
Science Ireland Ltd.